Skip to main content Accessibility help
×
Home

We need to do better: most people with dementia living in aged care facilities use antipsychotics for too long, for off-label indications and without documented consent

  • Lisa M. Kalisch Ellett (a1) and Renly Lim (a1)

Abstract

  • An abstract is not available for this content so a preview has been provided below. Please use the Get access link above for information on how to access this content.

Copyright

Corresponding author

References

Hide All
Australian Government Department of Health Therapeutic Goods Administration. (2015). Risperidone and risk of cerebrovascular adverse events in dementia patients. Medicines Safety Update, 6(4), 1.
Australian Institute of Health and Welfare. (2018). People leaving aged care. Available from: https://www.gen-agedcaredata.gov.au/www_aihwgen/media/2018-factsheets/People-leaving-aged-care-Fact-sheet-2017%e2%80%9318.pdf; last accessed 19 December 2019.
Brodaty, H.et al. (2018). Antipsychotic deprescription for older adults in long-term care: the HALT study. Journal of the American Medical Directors Association, 19, 592600.
Brown, L., Hansnata, E. and La, H. (2017). Economic cost of dementia in Australia 2016-2056. Canberra: NATSEM, Institute for Governance and Policy Analysis, University of Canberra.
Hálfdánarson, Ó.et al. (2017). International trends in antipsychotic use: a study in 16 countries, 2005–2014. European Neuropsychopharmacology, 27(10), 10641076.
Harrison, F.et al. (2020). Prolonged use of antipsychotic medications in long-term aged care in Australia: a snapshot from the HALT project. International Psychogeriatrics, 32, 335–345. doi: 10.1017/S1041610219002011.
Kalisch Ellett, L.M., Kassie, G.M., Pratt, N.L., Kerr, M. and Roughead, E.E. (2019). Prevalence and duration of use of medicines recommended for short-term use in aged care facility residents. Pharmacy (Basel, Switzerland), 7(2), E55.
Peisah, C., Jessop, T. and Breen, J. (2020). A missed opportunity to improve practice around the use of restraints and consent in residential aged care: Limitations of the Quality of Care Amendment (Minimising the Use of Restraints) Principles 2019. Australasian Journal on Ageing. doi: 10.1111/ajag.12757.
Pratt, N., Roughead, E.E., Ramsay, E., Salter, A. and Ryan, P. (2011). Risk of hospitalization for hip fracture and pneumonia associated with antipsychotic prescribing in the elderly. Drug Safety, 34(7), 567575.
Pratt, N., Roughead, E.E., Ryan, P. and Salter, A. (2010). Antipsychotics and the risk of death in the elderly: an instrumental variable analysis using two preference based instruments. Pharmacoepidemiology and Drug Safety, 19(7), 699707.
Royal Australian and New Zealand College of Psychiatrists. (2016). Professional Practice Guideline 10: Antipsychotic medications as a treatment of behavioural and psychological symptoms of dementia. Royal Australian and New Zealand College of Psychiatrists (RANZCP). Available from: https://www.ranzcp.org/files/resources/college_statements/practice_guidelines/pg10-pdf.aspx.
Royal Commission into Aged Care Quality and Safety. (2019). Interim Report. Available from: https://agedcare.royalcommission.gov.au/publications/Pages/interim-report.aspx.
Westaway, K., Sluggett, J., Alderman, C., Moffat, A., Procter, N. and Roughead, E. (2018). The extent of antipsychotic use in Australian residential aged care facilities and interventions shown to be effective in reducing antipsychotic use: a literature review. Dementia (London, England), 1471301218795792.
Westbury, J.et al. (2018). RedUSE: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Medical Journal of Australia, 208(9), 398403.
Yunusa, I., Alsumali, A., Garba, A., Regestein, Q. and Eguale, T. (2019). Assessment of reported comparative effectiveness and safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms of dementia A network meta-analysis. JAMA Network Open, 2(3), e190828.

We need to do better: most people with dementia living in aged care facilities use antipsychotics for too long, for off-label indications and without documented consent

  • Lisa M. Kalisch Ellett (a1) and Renly Lim (a1)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.